참고문헌
- Berkowitz AL. Tetanus, botulism, and diphtheria. Continuum (Minneap Minn) 2018;24:1459-1488. https://doi.org/10.1212/con.0000000000000651
- Wasay M, Khealani BA, Talati N, Shamsi R, Syed NA, Salahuddin N. Autonomic nervous system dysfunction predicts poor prognosis in patients with mild to moderate tetanus. BMC Neurol 2005;5:2. https://doi.org/10.1186/1471-2377-5-2
- Anuradha S. Tetanus in adults--a continuing problem: an analysis of 217 patients over 3 years from Delhi, India, with special emphasis on predictors of mortality. Med J Malaysia 2006;61:7-14.
- Korea Disease Control and Prevention Agency. Infectious disease portal report [Internet]. Cheongju, Korea: Korea Disease Control and Prevention Agency; c2021 [accessed 2021 Mar 15]. Available from: http://www.kdca.go.kr/npt/biz/npp/ist/simple/simplePd-StatsMain.do
- Abrutyn E. Tetanus. In: Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, eds. Harrison's principle's of internal medicine. 17th ed. New York: Mc Graw Hill Inc., 2008;898-900.
- Spruyt GM, Van Den Heever T. The treatment of autonomic dysfunction in tetanus. South Afr J Crit Care 2017;33:28-31.
- Farrar JJ, Yen LM, Cook T, Fairweather N, Binh N, Parry J, et al. Tetanus. J Neurol Neurosurg Psychiatry 2000;69:292-301. https://doi.org/10.1136/jnnp.69.3.292
- Rodrigo C, Fernando D, Rajapakse S. Pharmacological management of tetanus: an evidence-based review. Crit Care 2014;18:217. https://doi.org/10.1186/cc13797
- Dundee JW, Morrow WF. Labetalol in severe tetanus. Br Med J 1979;1:1121-1122. https://doi.org/10.1136/bmj.1.6171.1121
- Wesley AG, Hariparsad D, Pather M, Rocke DA. Labetalol in tetanus. The treatment of sympathetic nervous system overactivity. Anaesthesia 1983;38:243-249.